Clinical Trial Imaging Market projected to reach $2.45 billion by 2032, driven by advancements

From GlobeNewswire: 2025-01-15 09:37:00

The Clinical Trial Imaging Market was valued at USD 1.24 billion in 2023, projected to reach USD 2.45 billion by 2032, with a CAGR of 7.86%. Advancements in imaging tech and demand for precise diagnostics are driving growth. MRI dominates the market, with OCT’s usage increasing by 35% annually in ophthalmology trials. The market is supported by a surge in imaging service providers and pharmaceutical companies investing in advanced technologies to meet demand. North America leads the market, followed by Europe. The demand for imaging services is rising due to personalized medicine and increased clinical trials in oncology, neurology, and cardiovascular diseases. Asia-Pacific is the fastest-growing region, with China and India leading the growth, driven by expanding healthcare infrastructure and technological advancements. Recent developments include NUCLIDIUM’s successful imaging of the first patient in its Phase 1 study and Yunu offering free access to its platform for all clinical trials conducted by the Children’s Oncology Group.

For more detailed information and insights on the Clinical Trial Imaging Market, including key points, research methodology, market dynamics impact analysis, statistical insights, and trends reporting, visit the link provided. SNS Insider is a leading market research and consulting agency providing clients with accurate market data and insights to make informed decisions in changing circumstances.



Read more at GlobeNewswire: Clinical Trial Imaging Market Size to Reach USD 2.45